KVUEKenvue Inc.

NYSE www.jnj.com/kenvue/


$ 18.18 $ -0.24 (-1.3 %)    

Friday, 28-Jun-2024 15:59:56 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 18.18
$ 18.43
$ 0.00 x 0
$ 0.00 x 0
$ 18.04 - $ 18.59
$ 17.45 - $ 25.89
57,323,267
na
34.91B
$ 0.70
$ 23.41
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-03-2023 10-01-2023 10-Q
4 08-02-2023 07-02-2023 10-Q
5 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sanofi-looks-to-sell-20b-icy-hot-division-likely-bidders-include-advent-pai-partners-blackstone-cvc

Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.

 citigroup-reinstates-neutral-on-kenvue-announces-21-price-target

Citigroup analyst Filippo Falorni reinstates Kenvue (NYSE:KVUE) with a Neutral and announces $21 price target.

 pfizer-astrazeneca-sanofi-and-mainz-biomed-to-uplevel-europes-pharma-game

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will...

Core News & Articles

Kenvue Inc. (NYSE:KVUE) ("Kenvue") announced today the launch of a secondary underwritten public offering (the "Off...

 hsbc-maintains-hold-on-kenvue-raises-price-target-to-21

HSBC analyst Jeremy Fialko maintains Kenvue (NYSE:KVUE) with a Hold and raises the price target from $20 to $21.

 us-stocks-eye-fourth-positive-session-despite-hawkish-fed-remarks-disney-palantir-tumble-treasury-yields-fall-whats-driving-markets-tuesday

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...

 band-aid-maker-kenvue-cuts-workforce-by-4-q1-earnings-beat-street-expectations

Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essentia...

 johnson--johnson-childrens-cough-syrup-contaminated-in-some-batches---who-poised-to-issue-global-alert-updated

WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detect...

 bernstein-initiates-coverage-on-kenvue-with-underperform-rating-announces-price-target-of-18

Bernstein analyst Callum Elliott initiates coverage on Kenvue (NYSE:KVUE) with a Underperform rating and announces Price Tar...